RecruitingNCT06840977

COLON ERDERLY LOW DOSE

RETROSPECTIVE OBSERVATIONAL STUDY OF CHEMOTHERAPY IN ELDERLY PATIENTS IN THE FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER

Sponsor

Matteo Clavarezza

Enrollment

51 participants

Start Date

Jul 7, 2026

Study Type

OBSERVATIONAL

Conditions

Colon Adenocarcinoma

Summary

In this retrospective observational study, the case series of patients undergoing first-line treatment for metastatic colorectal adenocarcinoma with doublet fixed-dose and reduced-dose chemotherapy in combination with full-dose monoclonal antibody in patients aged 70 years or older is collected.

Eligibility

Min Age: 70 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with colon adenocarcinoma. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 70 Years to 99 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.